Trial reportJournal of cancer education : the official journal of the American Association for Cancer Education2025
Effect of Chemotherapy Patient Education Using the Teach-Back Method on Symptom Management and Quality of Life: A Randomized Controlled Trial.
Trial report in Journal of cancer education : the official journal of the American Association for Cancer Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Trial
- A nurse-led cross-sectional latent profile analysis of fear of cancer recurrence in patients with non-muscle-invasive bladder cancer.Medicine · 2026Article
- Telehealth education for patients with cancer: a standalone solution for symptom relief?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Impact of Oncology Patients' Knowledge and Awareness on Emergency Visits and Hospital Admissions: A Cross-Sectional Study.Cancer management and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the impact of the teach-back method in managing chemotherapy symptoms and improving quality of life. A secondary aim was to develop more effective care and education frameworks for cancer treatment. A single-center, randomized controlled trial was conducted with 80 patients who received chemotherapy between June 2022 and May 2023. Patients in the intervention group were educated about the chemotherapy process using the teach-back method, while those in the control group received standard education. Data were collected using a participant information form, the Edmonton Symptom Assessment Scale (ESAS), and the EQ-5D Quality of Life Scale. Statistical significance was accepted as p < 0.05 for all tests. In both groups, EQ-5D scores increased with the number of chemotherapy cycles, indicating a negative impact on quality of life. However, this increase was smaller in the intervention group. As the number of cycles increased, the intervention group scored lower on the Edmonton Symptom Assessment Scale compared to the control group. The results of the study show that using the teach-back method in patient education is effective in the management of chemotherapy-related symptoms and improving overall quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.